Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
Research ArticleArticle

Relationship Between the Dynamics of Telomere Loss in Peripheral Blood Leukocytes From Knee Osteoarthritis Patients and Mitochondrial DNA Haplogroups

Rebeca Guillén Fajardo, Fátima Otero Fariña, Alejandro Mosquera Rey, Ignacio Rego-Pérez, Francisco J. Blanco and José Luis Fernández García
The Journal of Rheumatology March 2021, jrheum.201316; DOI: https://doi.org/10.3899/jrheum.201316
Rebeca Guillén Fajardo
The work was supported by grants PI17/01987 and PI16/02124 from Fondo de Investigaciones Sanitarias (FIS), Instituto de Salud Carlos III, Spain, a part of the National Plan for Scientific Program, Development and Technological Innovation, 2013–2016, and the ISCIII-General Subdirection of Assessment and Promotion of Research-European Regional Development Fund (FEDER) "A way of making Europe," and grant IN607A 2017/11 from Xunta de Galicia. R. Guillén Fajardo, PhD student, F. Otero Fariña, PhD student, J.L. Fernández García, MD, PhD, INIBIC-Hospital Universitario A Coruña (CHUAC), Genetics Unit, and Centro Oncológico de Galicia, Laboratory of Genetics and Radiobiology; A. Mosquera Rey, PhD, INIBIC-Hospital Universitario A Coruña (CHUAC), Genetics Unit; I. Rego-Pérez, PhD, INIBIC-Hospital Universitario A Coruña (CHUAC), Rheumatology Division; F.J. Blanco, MD, PhD, INIBIC-Hospital Universitario A Coruña (CHUAC), Rheumatology Division, and Universidad de A Coruña, Department of Physiotherapy, Medicine and Biomedical Sciences, Strategic Group CICA-INIBIC, Rheumatology and Health Group, A Coruña, Spain. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. F.J. Blanco, Rheumatology Division, Hospital Universitario A Coruña (CHUAC) As Xubias, 84, 15006-A Coruña, Spain. Email: fblagar@sergas.es. Accepted for publication February 10, 2021.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Rebeca Guillén Fajardo
Fátima Otero Fariña
The work was supported by grants PI17/01987 and PI16/02124 from Fondo de Investigaciones Sanitarias (FIS), Instituto de Salud Carlos III, Spain, a part of the National Plan for Scientific Program, Development and Technological Innovation, 2013–2016, and the ISCIII-General Subdirection of Assessment and Promotion of Research-European Regional Development Fund (FEDER) "A way of making Europe," and grant IN607A 2017/11 from Xunta de Galicia. R. Guillén Fajardo, PhD student, F. Otero Fariña, PhD student, J.L. Fernández García, MD, PhD, INIBIC-Hospital Universitario A Coruña (CHUAC), Genetics Unit, and Centro Oncológico de Galicia, Laboratory of Genetics and Radiobiology; A. Mosquera Rey, PhD, INIBIC-Hospital Universitario A Coruña (CHUAC), Genetics Unit; I. Rego-Pérez, PhD, INIBIC-Hospital Universitario A Coruña (CHUAC), Rheumatology Division; F.J. Blanco, MD, PhD, INIBIC-Hospital Universitario A Coruña (CHUAC), Rheumatology Division, and Universidad de A Coruña, Department of Physiotherapy, Medicine and Biomedical Sciences, Strategic Group CICA-INIBIC, Rheumatology and Health Group, A Coruña, Spain. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. F.J. Blanco, Rheumatology Division, Hospital Universitario A Coruña (CHUAC) As Xubias, 84, 15006-A Coruña, Spain. Email: fblagar@sergas.es. Accepted for publication February 10, 2021.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Fátima Otero Fariña
Alejandro Mosquera Rey
The work was supported by grants PI17/01987 and PI16/02124 from Fondo de Investigaciones Sanitarias (FIS), Instituto de Salud Carlos III, Spain, a part of the National Plan for Scientific Program, Development and Technological Innovation, 2013–2016, and the ISCIII-General Subdirection of Assessment and Promotion of Research-European Regional Development Fund (FEDER) "A way of making Europe," and grant IN607A 2017/11 from Xunta de Galicia. R. Guillén Fajardo, PhD student, F. Otero Fariña, PhD student, J.L. Fernández García, MD, PhD, INIBIC-Hospital Universitario A Coruña (CHUAC), Genetics Unit, and Centro Oncológico de Galicia, Laboratory of Genetics and Radiobiology; A. Mosquera Rey, PhD, INIBIC-Hospital Universitario A Coruña (CHUAC), Genetics Unit; I. Rego-Pérez, PhD, INIBIC-Hospital Universitario A Coruña (CHUAC), Rheumatology Division; F.J. Blanco, MD, PhD, INIBIC-Hospital Universitario A Coruña (CHUAC), Rheumatology Division, and Universidad de A Coruña, Department of Physiotherapy, Medicine and Biomedical Sciences, Strategic Group CICA-INIBIC, Rheumatology and Health Group, A Coruña, Spain. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. F.J. Blanco, Rheumatology Division, Hospital Universitario A Coruña (CHUAC) As Xubias, 84, 15006-A Coruña, Spain. Email: fblagar@sergas.es. Accepted for publication February 10, 2021.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Alejandro Mosquera Rey
Ignacio Rego-Pérez
The work was supported by grants PI17/01987 and PI16/02124 from Fondo de Investigaciones Sanitarias (FIS), Instituto de Salud Carlos III, Spain, a part of the National Plan for Scientific Program, Development and Technological Innovation, 2013–2016, and the ISCIII-General Subdirection of Assessment and Promotion of Research-European Regional Development Fund (FEDER) "A way of making Europe," and grant IN607A 2017/11 from Xunta de Galicia. R. Guillén Fajardo, PhD student, F. Otero Fariña, PhD student, J.L. Fernández García, MD, PhD, INIBIC-Hospital Universitario A Coruña (CHUAC), Genetics Unit, and Centro Oncológico de Galicia, Laboratory of Genetics and Radiobiology; A. Mosquera Rey, PhD, INIBIC-Hospital Universitario A Coruña (CHUAC), Genetics Unit; I. Rego-Pérez, PhD, INIBIC-Hospital Universitario A Coruña (CHUAC), Rheumatology Division; F.J. Blanco, MD, PhD, INIBIC-Hospital Universitario A Coruña (CHUAC), Rheumatology Division, and Universidad de A Coruña, Department of Physiotherapy, Medicine and Biomedical Sciences, Strategic Group CICA-INIBIC, Rheumatology and Health Group, A Coruña, Spain. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. F.J. Blanco, Rheumatology Division, Hospital Universitario A Coruña (CHUAC) As Xubias, 84, 15006-A Coruña, Spain. Email: fblagar@sergas.es. Accepted for publication February 10, 2021.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ignacio Rego-Pérez
Francisco J. Blanco
The work was supported by grants PI17/01987 and PI16/02124 from Fondo de Investigaciones Sanitarias (FIS), Instituto de Salud Carlos III, Spain, a part of the National Plan for Scientific Program, Development and Technological Innovation, 2013–2016, and the ISCIII-General Subdirection of Assessment and Promotion of Research-European Regional Development Fund (FEDER) "A way of making Europe," and grant IN607A 2017/11 from Xunta de Galicia. R. Guillén Fajardo, PhD student, F. Otero Fariña, PhD student, J.L. Fernández García, MD, PhD, INIBIC-Hospital Universitario A Coruña (CHUAC), Genetics Unit, and Centro Oncológico de Galicia, Laboratory of Genetics and Radiobiology; A. Mosquera Rey, PhD, INIBIC-Hospital Universitario A Coruña (CHUAC), Genetics Unit; I. Rego-Pérez, PhD, INIBIC-Hospital Universitario A Coruña (CHUAC), Rheumatology Division; F.J. Blanco, MD, PhD, INIBIC-Hospital Universitario A Coruña (CHUAC), Rheumatology Division, and Universidad de A Coruña, Department of Physiotherapy, Medicine and Biomedical Sciences, Strategic Group CICA-INIBIC, Rheumatology and Health Group, A Coruña, Spain. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. F.J. Blanco, Rheumatology Division, Hospital Universitario A Coruña (CHUAC) As Xubias, 84, 15006-A Coruña, Spain. Email: fblagar@sergas.es. Accepted for publication February 10, 2021.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Francisco J. Blanco
José Luis Fernández García
The work was supported by grants PI17/01987 and PI16/02124 from Fondo de Investigaciones Sanitarias (FIS), Instituto de Salud Carlos III, Spain, a part of the National Plan for Scientific Program, Development and Technological Innovation, 2013–2016, and the ISCIII-General Subdirection of Assessment and Promotion of Research-European Regional Development Fund (FEDER) "A way of making Europe," and grant IN607A 2017/11 from Xunta de Galicia. R. Guillén Fajardo, PhD student, F. Otero Fariña, PhD student, J.L. Fernández García, MD, PhD, INIBIC-Hospital Universitario A Coruña (CHUAC), Genetics Unit, and Centro Oncológico de Galicia, Laboratory of Genetics and Radiobiology; A. Mosquera Rey, PhD, INIBIC-Hospital Universitario A Coruña (CHUAC), Genetics Unit; I. Rego-Pérez, PhD, INIBIC-Hospital Universitario A Coruña (CHUAC), Rheumatology Division; F.J. Blanco, MD, PhD, INIBIC-Hospital Universitario A Coruña (CHUAC), Rheumatology Division, and Universidad de A Coruña, Department of Physiotherapy, Medicine and Biomedical Sciences, Strategic Group CICA-INIBIC, Rheumatology and Health Group, A Coruña, Spain. The authors declare no conflicts of interest relevant to this article. Address correspondence to Dr. F.J. Blanco, Rheumatology Division, Hospital Universitario A Coruña (CHUAC) As Xubias, 84, 15006-A Coruña, Spain. Email: fblagar@sergas.es. Accepted for publication February 10, 2021.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for José Luis Fernández García
  • Article
  • Info & Metrics
  • References
  • PDF
  • eLetters
PreviousNext
Loading

Abstract

Objective To evaluate the evolution of telomere length from peripheral blood leukocytes (PBLs) in subjects from the Osteoarthritis Initiative (OAI) cohort in relation to the incidence of osteoarthritis (OA), and to explore its possible interactive influence with the mitochondrial DNA (mtDNA) haplogroup.

Methods Dynamics of telomere sequence loss were quantified in PBLs from initially healthy individuals (without symptoms or radiological signs), 78 carrying the mtDNA cluster HV, and 47 with cluster JT, from the OAI, during a 72-month follow-up period. The incidence of knee OA during this period (n = 39) was radiographically established when Kellgren-Lawrence (KL) score increased from < 2 at recruitment, to ≥ 2 at the end of 72 months of follow-up. Multivariate analysis using binary logistic regression was performed to assess PBL telomere loss and mtDNA haplogroups as associated risk factors of incidence of knee OA.

Results Carriers of cluster HV showed knee OA incidence twice that of the JT carriers (n = 30 vs 9). The rate of PBL telomere loss was higher in cluster HV carriers and in individuals with incident knee OA. Multivariate analysis showed that the dynamics of PBL telomere shortening can be a consistent risk marker of knee OA incidence. Subjects with nonincident knee OA showed a slower telomere loss than those with incident knee OA; the difference was more significant in carriers of cluster JT than in HV.

Conclusion An increased rate of telomere loss in PBLs may reflect a systemic accelerated senescence phenotype that could be potentiated by the mitochondrial function, increasing the susceptibility of developing knee OA.

PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 50, Issue 3
1 Mar 2023
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Relationship Between the Dynamics of Telomere Loss in Peripheral Blood Leukocytes From Knee Osteoarthritis Patients and Mitochondrial DNA Haplogroups
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Relationship Between the Dynamics of Telomere Loss in Peripheral Blood Leukocytes From Knee Osteoarthritis Patients and Mitochondrial DNA Haplogroups
Rebeca Guillén Fajardo, Fátima Otero Fariña, Alejandro Mosquera Rey, Ignacio Rego-Pérez, Francisco J. Blanco, José Luis Fernández García
The Journal of Rheumatology Mar 2021, jrheum.201316; DOI: 10.3899/jrheum.201316

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
Relationship Between the Dynamics of Telomere Loss in Peripheral Blood Leukocytes From Knee Osteoarthritis Patients and Mitochondrial DNA Haplogroups
Rebeca Guillén Fajardo, Fátima Otero Fariña, Alejandro Mosquera Rey, Ignacio Rego-Pérez, Francisco J. Blanco, José Luis Fernández García
The Journal of Rheumatology Mar 2021, jrheum.201316; DOI: 10.3899/jrheum.201316
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • References
  • PDF
  • eLetters

Related Articles

Cited By...

More in this TOC Section

  • Long-Term Safety and Efficacy of Ixekizumab in Patients With Axial Spondyloarthritis: 3-year Data From the COAST Program
  • Do Patterns of Early Disease Severity Predict Grade 12 Academic Achievement in Youths With Childhood-Onset Chronic Rheumatic Diseases?
  • Pediatric Sarcoidosis: Retrospective Analysis of Biopsy-Proven Patients
Show more Articles

Similar Articles

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2022 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire